Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
The analysis (Table 2) revealed that transcript levels of miRNAs did not have statistically significant differences in osteoporosis patients according to the groups by gender (male vs. female), smoking status (smoker vs. non-smoker), residency status (urbane vs. rural), hypertension (yes vs. no), diabetes mellitus (yes vs. no), vitamin D supplement use (yes vs. no), calcium supplement use (yes vs. no), job (working/not working), marital status (married/single), education (educated/non-educated), familial history of Osteoporosis (Yes/No), bone fracture history (Yes/No), and familial History of bone fracture (Yes/No).
Source: Association of Zn level and miRNA expression with patient’s data. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Case-control study.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
In this case-control study, 50 patients with osteoporosis and 50 healthy controls were recruited.
Source: Abstract.
Participants were selected based on specific inclusion criteria, excluding individuals with conditions such as liver or kidney failure, thyroid or parathyroid disorders, hematological conditions (e.g., anemia, thrombocytopenia, leukopenia), malignancies, autoimmune diseases (e.g., ankylosing spondylitis, rheumatoid arthritis, systemic lupus erythematosus), hip or spine fractures, active infections, or a history of blood transfusion within the past year.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
The role of serum zinc and MicroRNAs in osteoporosis: insights into bone metabolism and potential diagnostic markers
Case-control study · BMC Musculoskeletal Disorders · 2025
Original publication title
The role of serum zinc and MicroRNAs in osteoporosis: insights into bone metabolism and potential diagnostic markers
© The Author(s) 2025
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Zinc (Zn) levels are reportedly lower in osteoporosis patients and may be linked to bone health. MicroRNAs (miRNAs) have also been implicated in the regulation of bone remodeling. This study aims to investigate the role of selected miRNAs and their potential interplay with Zn in the pathogenesis of osteoporosis.
Source: BackgroundAbstract: What methods does the paper describe?
In this case-control study, 50 patients with osteoporosis and 50 healthy controls were recruited. The serum transcript levels of miRNAs were assessed using Real-time PCR.
Source: MethodsAbstract: Results
Levels of Zn was significantly (P = 0.0047) lower in the serum samples from osteoporosis patients in comparison to the healthy controls. The transcript level of miR-34a-5p (Fold change = 2.59, P = 0.008) and miR-335-5p (Fold change = 1.90, P = 0.013) was upregulated significantly in the serum samples of patients with osteoporosis compared to that of the healthy controls. Zn level in osteoporosis patients had significant negative correlation with transcript levels of miR-335-5p (r= -0.24, P = 0.037).
Zn level had positive correlation with Z and T-scores and BMD of hip, spine, and femur. A negative correlation (r= -0.28 P = 0.044) was detected between transcript level of miR-34a-5p and femur BMD. There was a significant negative correlation between transcript level of miR-335-5p and hip BMD (r= -0.19 P = 0.038). miR-34a-5p and miR-335-5p showed diagnostic potential.
Source: ResultsAbstract: Conclusions
The findings suggest a potential interplay between Zn and miRNAs in the regulation of bone metabolism in osteoporosis patients. Zn and miRNAs may serve as biomarkers for bone health and a therapeutic target in osteoporosis management.
Source: ConclusionsAuthors’ abstract
Background
Zinc (Zn) levels are reportedly lower in osteoporosis patients and may be linked to bone health. MicroRNAs (miRNAs) have also been implicated in the regulation of bone remodeling. This study aims to investigate the role of selected miRNAs and their potential interplay with Zn in the pathogenesis of osteoporosis.
Methods
In this case-control study, 50 patients with osteoporosis and 50 healthy controls were recruited. The serum transcript levels of miRNAs were assessed using Real-time PCR.
Results
Levels of Zn was significantly (P = 0.0047) lower in the serum samples from osteoporosis patients in comparison to the healthy controls. The transcript level of miR-34a-5p (Fold change = 2.59, P = 0.008) and miR-335-5p (Fold change = 1.90, P = 0.013) was upregulated significantly in the serum samples of patients with osteoporosis compared to that of the healthy controls. Zn level in osteoporosis patients had significant negative correlation with transcript levels of miR-335-5p (r= -0.24, P = 0.037).
Zn level had positive correlation with Z and T-scores and BMD of hip, spine, and femur. A negative correlation (r= -0.28 P = 0.044) was detected between transcript level of miR-34a-5p and femur BMD. There was a significant negative correlation between transcript level of miR-335-5p and hip BMD (r= -0.19 P = 0.038). miR-34a-5p and miR-335-5p showed diagnostic potential.
Conclusions
The findings suggest a potential interplay between Zn and miRNAs in the regulation of bone metabolism in osteoporosis patients. Zn and miRNAs may serve as biomarkers for bone health and a therapeutic target in osteoporosis management.
Supplementary Information
The online version contains supplementary material available at 10.1186/s12891-025-08970-9.
Publication and source details
Original title: The role of serum zinc and MicroRNAs in osteoporosis: insights into bone metabolism and potential diagnostic markers
Parastoo Karimi; Mohammad Reza Mirzaei; Farzaneh Arami; Zahra Bagheri-Hosseinabadi; Mitra Abbasifard; Saeed Mohammadi-Hosseinabad; Zahra Jalali; Mehdi Mahmoodi; Mohammad Reza Hajizadeh
BMC Musculoskeletal Disorders · 2025
© The Author(s) 20252025https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.https://doi.org/10.13039/100017332Rafsanjan University of Medical SciencesRepository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T03:29:51.829195+00:00
DOI: 10.1186/s12891-025-08970-9 · PMC12335165